Chapter/Section Purchase

Leave This Empty:

2023-2028 Global and Regional Targeted Drug Delivery System Industry Status and Prospects Professional Market Research Report Standard Version

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2023-2028)

1.4.2 East Asia Market States and Outlook (2023-2028)

1.4.3 Europe Market States and Outlook (2023-2028)

1.4.4 South Asia Market States and Outlook (2023-2028)

1.4.5 Southeast Asia Market States and Outlook (2023-2028)

1.4.6 Middle East Market States and Outlook (2023-2028)

1.4.7 Africa Market States and Outlook (2023-2028)

1.4.8 Oceania Market States and Outlook (2023-2028)

1.4.9 South America Market States and Outlook (2023-2028)

1.5 Global Targeted Drug Delivery System Market Size Analysis from 2023 to 2028

1.5.1 Global Targeted Drug Delivery System Market Size Analysis from 2023 to 2028 by Consumption Volume

1.5.2 Global Targeted Drug Delivery System Market Size Analysis from 2023 to 2028 by Value

1.5.3 Global Targeted Drug Delivery System Price Trends Analysis from 2023 to 2028

1.6 COVID-19 Outbreak: Targeted Drug Delivery System Industry Impact

Chapter 2 Global Targeted Drug Delivery System Competition by Types, Applications, and Top Regions and Countries

2.1 Global Targeted Drug Delivery System (Volume and Value) by Type

2.1.1 Global Targeted Drug Delivery System Consumption and Market Share by Type (2017-2022)

2.1.2 Global Targeted Drug Delivery System Revenue and Market Share by Type (2017-2022)

2.2 Global Targeted Drug Delivery System (Volume and Value) by Application

2.2.1 Global Targeted Drug Delivery System Consumption and Market Share by Application (2017-2022)

2.2.2 Global Targeted Drug Delivery System Revenue and Market Share by Application (2017-2022)

2.3 Global Targeted Drug Delivery System (Volume and Value) by Regions

2.3.1 Global Targeted Drug Delivery System Consumption and Market Share by Regions (2017-2022)

2.3.2 Global Targeted Drug Delivery System Revenue and Market Share by Regions (2017-2022)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2017-2022 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2017-2022 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Targeted Drug Delivery System Sales, Consumption, Export, Import by Regions (2017-2022)

4.1 Global Targeted Drug Delivery System Consumption by Regions (2017-2022)

4.2 North America Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.3 East Asia Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.4 Europe Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.5 South Asia Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.6 Southeast Asia Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.7 Middle East Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.8 Africa Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.9 Oceania Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

4.10 South America Targeted Drug Delivery System Sales, Consumption, Export, Import (2017-2022)

Chapter 5 North America Targeted Drug Delivery System Market Analysis

5.1 North America Targeted Drug Delivery System Consumption and Value Analysis

5.1.1 North America Targeted Drug Delivery System Market Under COVID-19

5.2 North America Targeted Drug Delivery System Consumption Volume by Types

5.3 North America Targeted Drug Delivery System Consumption Structure by Application

5.4 North America Targeted Drug Delivery System Consumption by Top Countries

5.4.1 United States Targeted Drug Delivery System Consumption Volume from 2017 to 2022

5.4.2 Canada Targeted Drug Delivery System Consumption Volume from 2017 to 2022

5.4.3 Mexico Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 6 East Asia Targeted Drug Delivery System Market Analysis

6.1 East Asia Targeted Drug Delivery System Consumption and Value Analysis

6.1.1 East Asia Targeted Drug Delivery System Market Under COVID-19

6.2 East Asia Targeted Drug Delivery System Consumption Volume by Types

6.3 East Asia Targeted Drug Delivery System Consumption Structure by Application

6.4 East Asia Targeted Drug Delivery System Consumption by Top Countries

6.4.1 China Targeted Drug Delivery System Consumption Volume from 2017 to 2022

6.4.2 Japan Targeted Drug Delivery System Consumption Volume from 2017 to 2022

6.4.3 South Korea Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 7 Europe Targeted Drug Delivery System Market Analysis

7.1 Europe Targeted Drug Delivery System Consumption and Value Analysis

7.1.1 Europe Targeted Drug Delivery System Market Under COVID-19

7.2 Europe Targeted Drug Delivery System Consumption Volume by Types

7.3 Europe Targeted Drug Delivery System Consumption Structure by Application

7.4 Europe Targeted Drug Delivery System Consumption by Top Countries

7.4.1 Germany Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.2 UK Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.3 France Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.4 Italy Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.5 Russia Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.6 Spain Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.7 Netherlands Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.8 Switzerland Targeted Drug Delivery System Consumption Volume from 2017 to 2022

7.4.9 Poland Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 8 South Asia Targeted Drug Delivery System Market Analysis

8.1 South Asia Targeted Drug Delivery System Consumption and Value Analysis

8.1.1 South Asia Targeted Drug Delivery System Market Under COVID-19

8.2 South Asia Targeted Drug Delivery System Consumption Volume by Types

8.3 South Asia Targeted Drug Delivery System Consumption Structure by Application

8.4 South Asia Targeted Drug Delivery System Consumption by Top Countries

8.4.1 India Targeted Drug Delivery System Consumption Volume from 2017 to 2022

8.4.2 Pakistan Targeted Drug Delivery System Consumption Volume from 2017 to 2022

8.4.3 Bangladesh Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 9 Southeast Asia Targeted Drug Delivery System Market Analysis

9.1 Southeast Asia Targeted Drug Delivery System Consumption and Value Analysis

9.1.1 Southeast Asia Targeted Drug Delivery System Market Under COVID-19

9.2 Southeast Asia Targeted Drug Delivery System Consumption Volume by Types

9.3 Southeast Asia Targeted Drug Delivery System Consumption Structure by Application

9.4 Southeast Asia Targeted Drug Delivery System Consumption by Top Countries

9.4.1 Indonesia Targeted Drug Delivery System Consumption Volume from 2017 to 2022

9.4.2 Thailand Targeted Drug Delivery System Consumption Volume from 2017 to 2022

9.4.3 Singapore Targeted Drug Delivery System Consumption Volume from 2017 to 2022

9.4.4 Malaysia Targeted Drug Delivery System Consumption Volume from 2017 to 2022

9.4.5 Philippines Targeted Drug Delivery System Consumption Volume from 2017 to 2022

9.4.6 Vietnam Targeted Drug Delivery System Consumption Volume from 2017 to 2022

9.4.7 Myanmar Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 10 Middle East Targeted Drug Delivery System Market Analysis

10.1 Middle East Targeted Drug Delivery System Consumption and Value Analysis

10.1.1 Middle East Targeted Drug Delivery System Market Under COVID-19

10.2 Middle East Targeted Drug Delivery System Consumption Volume by Types

10.3 Middle East Targeted Drug Delivery System Consumption Structure by Application

10.4 Middle East Targeted Drug Delivery System Consumption by Top Countries

10.4.1 Turkey Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.2 Saudi Arabia Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.3 Iran Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.4 United Arab Emirates Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.5 Israel Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.6 Iraq Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.7 Qatar Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.8 Kuwait Targeted Drug Delivery System Consumption Volume from 2017 to 2022

10.4.9 Oman Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 11 Africa Targeted Drug Delivery System Market Analysis

11.1 Africa Targeted Drug Delivery System Consumption and Value Analysis

11.1.1 Africa Targeted Drug Delivery System Market Under COVID-19

11.2 Africa Targeted Drug Delivery System Consumption Volume by Types

11.3 Africa Targeted Drug Delivery System Consumption Structure by Application

11.4 Africa Targeted Drug Delivery System Consumption by Top Countries

11.4.1 Nigeria Targeted Drug Delivery System Consumption Volume from 2017 to 2022

11.4.2 South Africa Targeted Drug Delivery System Consumption Volume from 2017 to 2022

11.4.3 Egypt Targeted Drug Delivery System Consumption Volume from 2017 to 2022

11.4.4 Algeria Targeted Drug Delivery System Consumption Volume from 2017 to 2022

11.4.5 Morocco Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 12 Oceania Targeted Drug Delivery System Market Analysis

12.1 Oceania Targeted Drug Delivery System Consumption and Value Analysis

12.2 Oceania Targeted Drug Delivery System Consumption Volume by Types

12.3 Oceania Targeted Drug Delivery System Consumption Structure by Application

12.4 Oceania Targeted Drug Delivery System Consumption by Top Countries

12.4.1 Australia Targeted Drug Delivery System Consumption Volume from 2017 to 2022

12.4.2 New Zealand Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 13 South America Targeted Drug Delivery System Market Analysis

13.1 South America Targeted Drug Delivery System Consumption and Value Analysis

13.1.1 South America Targeted Drug Delivery System Market Under COVID-19

13.2 South America Targeted Drug Delivery System Consumption Volume by Types

13.3 South America Targeted Drug Delivery System Consumption Structure by Application

13.4 South America Targeted Drug Delivery System Consumption Volume by Major Countries

13.4.1 Brazil Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.2 Argentina Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.3 Columbia Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.4 Chile Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.5 Venezuela Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.6 Peru Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.7 Puerto Rico Targeted Drug Delivery System Consumption Volume from 2017 to 2022

13.4.8 Ecuador Targeted Drug Delivery System Consumption Volume from 2017 to 2022

Chapter 14 Company Profiles and Key Figures in Targeted Drug Delivery System Business

14.1 3M Company

14.1.1 3M Company Company Profile

14.1.2 3M Company Targeted Drug Delivery System Product Specification

14.1.3 3M Company Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.2 Abbott Laboratories

14.2.1 Abbott Laboratories Company Profile

14.2.2 Abbott Laboratories Targeted Drug Delivery System Product Specification

14.2.3 Abbott Laboratories Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.3 Ablynx NV

14.3.1 Ablynx NV Company Profile

14.3.2 Ablynx NV Targeted Drug Delivery System Product Specification

14.3.3 Ablynx NV Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.4 Aciont Inc

14.4.1 Aciont Inc Company Profile

14.4.2 Aciont Inc Targeted Drug Delivery System Product Specification

14.4.3 Aciont Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.5 Acrux

14.5.1 Acrux Company Profile

14.5.2 Acrux Targeted Drug Delivery System Product Specification

14.5.3 Acrux Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.6 Agilis Biotherapeutics LLC

14.6.1 Agilis Biotherapeutics LLC Company Profile

14.6.2 Agilis Biotherapeutics LLC Targeted Drug Delivery System Product Specification

14.6.3 Agilis Biotherapeutics LLC Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.7 Aileron Therapeutics Inc

14.7.1 Aileron Therapeutics Inc Company Profile

14.7.2 Aileron Therapeutics Inc Targeted Drug Delivery System Product Specification

14.7.3 Aileron Therapeutics Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.8 Nano Precision Medical Inc

14.8.1 Nano Precision Medical Inc Company Profile

14.8.2 Nano Precision Medical Inc Targeted Drug Delivery System Product Specification

14.8.3 Nano Precision Medical Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.9 Novartis Pharmaceuticals Corp

14.9.1 Novartis Pharmaceuticals Corp Company Profile

14.9.2 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Product Specification

14.9.3 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.10 Oxford Biomedica

14.10.1 Oxford Biomedica Company Profile

14.10.2 Oxford Biomedica Targeted Drug Delivery System Product Specification

14.10.3 Oxford Biomedica Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.11 PharmaIN Corp

14.11.1 PharmaIN Corp Company Profile

14.11.2 PharmaIN Corp Targeted Drug Delivery System Product Specification

14.11.3 PharmaIN Corp Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.12 PolyMicrospheres

14.12.1 PolyMicrospheres Company Profile

14.12.2 PolyMicrospheres Targeted Drug Delivery System Product Specification

14.12.3 PolyMicrospheres Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.13 Presage Biosciences Inc

14.13.1 Presage Biosciences Inc Company Profile

14.13.2 Presage Biosciences Inc Targeted Drug Delivery System Product Specification

14.13.3 Presage Biosciences Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.14 Pulmatrix Inc

14.14.1 Pulmatrix Inc Company Profile

14.14.2 Pulmatrix Inc Targeted Drug Delivery System Product Specification

14.14.3 Pulmatrix Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.15 Quark Pharmaceuticals Inc

14.15.1 Quark Pharmaceuticals Inc Company Profile

14.15.2 Quark Pharmaceuticals Inc Targeted Drug Delivery System Product Specification

14.15.3 Quark Pharmaceuticals Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.16 RegeneRx Biopharmaceuticals Inc

14.16.1 RegeneRx Biopharmaceuticals Inc Company Profile

14.16.2 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Product Specification

14.16.3 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.17 Replicor Inc

14.17.1 Replicor Inc Company Profile

14.17.2 Replicor Inc Targeted Drug Delivery System Product Specification

14.17.3 Replicor Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.18 Rexahn Pharmaceuticals Inc

14.18.1 Rexahn Pharmaceuticals Inc Company Profile

14.18.2 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Product Specification

14.18.3 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.19 Roche Holding AG

14.19.1 Roche Holding AG Company Profile

14.19.2 Roche Holding AG Targeted Drug Delivery System Product Specification

14.19.3 Roche Holding AG Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.20 Savara Inc

14.20.1 Savara Inc Company Profile

14.20.2 Savara Inc Targeted Drug Delivery System Product Specification

14.20.3 Savara Inc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.21 Serina Therapeutics Inc.

14.21.1 Serina Therapeutics Inc. Company Profile

14.21.2 Serina Therapeutics Inc. Targeted Drug Delivery System Product Specification

14.21.3 Serina Therapeutics Inc. Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.22 Silenseed Ltd.

14.22.1 Silenseed Ltd. Company Profile

14.22.2 Silenseed Ltd. Targeted Drug Delivery System Product Specification

14.22.3 Silenseed Ltd. Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.23 SoluBest Ltd

14.23.1 SoluBest Ltd Company Profile

14.23.2 SoluBest Ltd Targeted Drug Delivery System Product Specification

14.23.3 SoluBest Ltd Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.24 Suda Ltd

14.24.1 Suda Ltd Company Profile

14.24.2 Suda Ltd Targeted Drug Delivery System Product Specification

14.24.3 Suda Ltd Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.25 Taiwan Liposome Co. Ltd.

14.25.1 Taiwan Liposome Co. Ltd. Company Profile

14.25.2 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Product Specification

14.25.3 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.26 Pipeline

14.26.1 Pipeline Company Profile

14.26.2 Pipeline Targeted Drug Delivery System Product Specification

14.26.3 Pipeline Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.27 Vect-Horus S.A.S.

14.27.1 Vect-Horus S.A.S. Company Profile

14.27.2 Vect-Horus S.A.S. Targeted Drug Delivery System Product Specification

14.27.3 Vect-Horus S.A.S. Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.28 Vectura Group plc

14.28.1 Vectura Group plc Company Profile

14.28.2 Vectura Group plc Targeted Drug Delivery System Product Specification

14.28.3 Vectura Group plc Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.29 WAVE Life Sciences Pvt. Ltd.

14.29.1 WAVE Life Sciences Pvt. Ltd. Company Profile

14.29.2 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Product Specification

14.29.3 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.30 Xigen SA

14.30.1 Xigen SA Company Profile

14.30.2 Xigen SA Targeted Drug Delivery System Product Specification

14.30.3 Xigen SA Targeted Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Chapter 15 Global Targeted Drug Delivery System Market Forecast (2023-2028)

15.1 Global Targeted Drug Delivery System Consumption Volume, Revenue and Price Forecast (2023-2028)

15.1.1 Global Targeted Drug Delivery System Consumption Volume and Growth Rate Forecast (2023-2028)

15.1.2 Global Targeted Drug Delivery System Value and Growth Rate Forecast (2023-2028)

15.2 Global Targeted Drug Delivery System Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)

15.2.1 Global Targeted Drug Delivery System Consumption Volume and Growth Rate Forecast by Regions (2023-2028)

15.2.2 Global Targeted Drug Delivery System Value and Growth Rate Forecast by Regions (2023-2028)

15.2.3 North America Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.4 East Asia Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.5 Europe Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.6 South Asia Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.7 Southeast Asia Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.8 Middle East Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.9 Africa Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.10 Oceania Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.11 South America Targeted Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.3 Global Targeted Drug Delivery System Consumption Volume, Revenue and Price Forecast by Type (2023-2028)

15.3.1 Global Targeted Drug Delivery System Consumption Forecast by Type (2023-2028)

15.3.2 Global Targeted Drug Delivery System Revenue Forecast by Type (2023-2028)

15.3.3 Global Targeted Drug Delivery System Price Forecast by Type (2023-2028)

15.4 Global Targeted Drug Delivery System Consumption Volume Forecast by Application (2023-2028)

15.5 Targeted Drug Delivery System Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology